Cotización Pandion Therapeutics, Inc.
Acciones
PAND
US6983401067
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01/06/17 | |
John Sundy
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,86 % | 108 mil M | |
+9,38 % | 104 mil M | |
+6,58 % | 23,66 mil M | |
-12,18 % | 22,1 mil M | |
-3,29 % | 19,71 mil M | |
-35,36 % | 18,2 mil M | |
-12,97 % | 16,19 mil M | |
+3,86 % | 13,72 mil M | |
+33,29 % | 12,22 mil M |